According to British Society for Haematology (BSH) guidelines and NICE Clinical Knowledge Summaries (CKS), the primary beneficiaries include: Key patient groups who may require B12 injections include: Pernicious anaemia patients requiring lifelong hydroxocobalamin 1mg intramuscularly every 23 months following initial loading doses Patients with gastrointestinal disorders including those who have undergone gastrectomy or ileal resection, and patients with conditions affecting B12 absorption such as Crohn's disease or coeliac disease Strict vegans and vegetarians though oral supplementation is usually sufficient unless malabsorption is present Elderly patients who may have reduced gastric acid production affecting B12 absorption Patients taking certain medications including metformin (MHRA advises monitoring B12 levels in long-term users, particularly those with risk factors or symptoms), proton pump inhibitors, and H2-receptor antagonists long-term [6] Individuals with neurological symptoms such as paraesthesia, ataxia, or cognitive impairment related to B12 deficiency Pregnant women with confirmed deficiency (hydroxocobalamin for malabsorption
When to Use Injections Injections are best suited for patients who are looking for rapid results, especially those who are dealing with significant energy depletion or metabolic issues
Side effects are: Red rash Increase skin acne Photosensitivity Bruising and bleeding at the injection site Vitamin D Vitamin D contributes to normal absorption/utilisation of calcium and phosphorus Contributes to normal blood calcium levels Contributes to the maintenance of normal bones Contributes to the maintenance of normal muscle function Contributes to the maintenance of normal teeth Contributes to the normal function of the immune system Has a role in the process of cell division Helps to reduce the risk of falling associated with postural instability and muscle weakness
Healthcare providers should emphasize evidence-based interventions aligned with current clinical guidelines from organizations such as the American Diabetes Association, American Association of Clinical Endocrinology, and American Gastroenterological Association
all tests were two-tailed and = 0.05 for each analysis
